NCT04622891View on ClinicalTrials.gov

Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

July 30, 2020

Study Completion Date

July 30, 2020

Conditions
Covid19
Interventions
DRUG

Clarithromycin 500mg

clarithromycin 500

DRUG

Azithromycin

azithromycin group

DRUG

Placebo

control group

Trial Locations (1)

868532

south-Vally University faculty of medicine, Qina

All Listed Sponsors
lead

South Valley University

OTHER

NCT04622891 - Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection | Biotech Hunter | Biotech Hunter